Wu Luo

3.2k total citations
92 papers, 2.5k citations indexed

About

Wu Luo is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Wu Luo has authored 92 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 29 papers in Immunology and 21 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Wu Luo's work include Immune Response and Inflammation (13 papers), Immune cells in cancer (13 papers) and Cardiovascular Function and Risk Factors (10 papers). Wu Luo is often cited by papers focused on Immune Response and Inflammation (13 papers), Immune cells in cancer (13 papers) and Cardiovascular Function and Risk Factors (10 papers). Wu Luo collaborates with scholars based in China, Canada and Thailand. Wu Luo's co-authors include Guang Liang, Gaojun Wu, Guang Liang, Weijian Huang, Yi Wang, Yi Wang, Jianchang Qian, Weiwei Zhu, Yiyi Jin and Ke Lin and has published in prestigious journals such as Nature Communications, Circulation Research and Hypertension.

In The Last Decade

Wu Luo

86 papers receiving 2.4k citations

Peers

Countries citing papers authored by Wu Luo

Since Specialization

Citations

This map shows the geographic impact of Wu Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wu Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wu Luo more than expected).

Fields of papers citing papers by Wu Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wu Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wu Luo. The network helps show where Wu Luo may publish in the future.

Co-authorship network of co-authors of Wu Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Wu Luo. A scholar is included among the top collaborators of Wu Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wu Luo. Wu Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Schisandrin B alleviates angiotensin II-induced cardiac inflammatory remodeling by inhibiting the recruitment of MyD88 to TLRs in mouse cardiomyocytes 2024 ·International Immunopharmacology ·(unknown), (unknown), Jibo Han, Wu Luo, Lijiang Huang, Yongsheng Jiang, А. В. Самородов, Yi Wang, (unknown)	3
2	OTUD1 promotes isoprenaline- and myocardial infarction-induced heart failure by targeting PDE5A in cardiomyocytes 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Qinyan Wang, Shiqi Liang, Jinfu Qian, Jiachen Xu, (unknown), (unknown), (unknown), (unknown), Gaojun Wu, (unknown), Wu Luo, Guang Liang	12
3	Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), Weiwei Zhu, (unknown), Qianhui Zhang, Minxiu Wang, (unknown), Yongqiang Xiong, Jiachen Xu, Qinyan Wang, Gaozhi Chen, Guang Liang, Xiang Hu, Wu Luo	4
4	Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Lijun Ji, Xiaojing Yang, Yiyi Jin, Li Li, Bin Yang, Weiwei Zhu, Ming‐Jiang Xu, Yi Wang, Gaojun Wu, Wu Luo, Kwang-Youl Lee, Guang Liang	3
5	CARD9 deficiency aggravated nonalcoholic steatohepatitis in mice through increasing inflammatory response 2023 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Xin Liu, (unknown), Chenchen Qian, (unknown), Wu Luo, (unknown), Jianjun Lin, (unknown), Guang Liang, Lijiang Huang, Yi Wang	3
6	Compound c17 alleviates inflammatory cardiomyopathy in streptozotocin-induced diabetic mice by targeting MyD88 2023 ·International Immunopharmacology ·Qianhui Zhang, Weiwei Zhu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Minxiu Wang, (unknown), Guang Liang, Wu Luo, Yi Wang	1
7	Isoproterenol induces MD2 activation by β-AR-cAMP-PKA-ROS signalling axis in cardiomyocytes and macrophages drives inflammatory heart failure 2023 ·Acta Pharmacologica Sinica ·(unknown), Shiqi Liang, (unknown), Jiachen Xu, Wu Luo, Weijian Huang, Gaojun Wu, Guang Liang	21
8	Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses 2023 ·EMBO Molecular Medicine ·(unknown), (unknown), Xue Han, Weixin Li, Wu Luo, Liming Lin, Mingjiang Xu, Yi Wang, Weijian Huang, Gaojun Wu, Guang Liang	31
9	Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ 2023 ·Cell Death and Differentiation ·Wu Luo, Yiyi Jin, Yuchen Jiang, Libin Yang, (unknown), Di Wu, Yanmei Zhang, Lina Yin, Zia A. Khan, Guang Liang, Yi Wang	13
10	Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling 2023 ·Circulation Research ·Shiju Ye, (unknown), Xue Han, Wu Luo, (unknown), Yang Ye, (unknown), (unknown), Weijian Huang, Yi Wang, (unknown), Guosheng Fu, Guang Liang	27
11	USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes 2023 ·Circulation Research ·Bozhi Ye, Hao Zhou, (unknown), Wu Luo, (unknown), Ying‐Yong Zhao, Jibo Han, Xue Han, Weijian Huang, Gaojun Wu, Xu Wang, Guang Liang	76
12	Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation 2022 ·Phytomedicine ·(unknown), Wu Luo, (unknown), Siyuan Shen, Zhe Wang, Ruijie Chen, (unknown), Nipon Chattipakorn, Weijian Huang, Guang Liang	19
13	Schisandrin B protects against LPS-induced inflammatory lung injury by targeting MyD88 2022 ·Phytomedicine ·Weiwei Zhu, Wu Luo, Jibo Han, Qiuyan Zhang, Lijun Ji, А. В. Самородов, В. Н. Павлов, (unknown), (unknown), Lina Yin, (unknown), Guang Liang, Joo Young Huh, Yi Wang	25
14	Sclareol attenuates angiotensin II‐induced cardiac remodeling and inflammation via inhibiting MAPK signaling 2022 ·Phytotherapy Research ·Na Yang, Chunpeng Zou, Wu Luo, (unknown), (unknown), Yi Wang, Gaojun Wu, Peiren Shan, Guang Liang	16
15	Ang II (Angiotensin II)–Induced FGFR1 (Fibroblast Growth Factor Receptor 1) Activation in Tubular Epithelial Cells Promotes Hypertensive Kidney Fibrosis and Injury 2022 ·Hypertension ·Zheng Xu, Wu Luo, Lingfeng Chen, (unknown), (unknown), Jianchang Qian, Zia A. Khan, Xinfu Guan, Yi Wang, Xiaokun Li, Guang Liang	29
16	Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway 2022 ·Phytomedicine ·(unknown), Wu Luo, (unknown), Shiqi Liang, Chunpeng Zou, Jinfeng Sun, Gao Li, Guang Liang	10
17	Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway 2022 ·Phytomedicine ·Siyuan Shen, Gaojun Wu, Wu Luo, Weixin Li, Xiaobo Li, (unknown), Weijian Huang, Guang Liang	23
18	MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy 2020 ·Nature Communications ·Yi Wang, Wu Luo, Jibo Han, Zia A. Khan, Qilu Fang, Yiyi Jin, Xuemei Chen, (unknown), Meihong Wang, Jianchang Qian, Weijian Huang, Hazel Lum, Gaojun Wu, Guang Liang	110
19	Celastrol Attenuates Angiotensin II–Induced Cardiac Remodeling by Targeting STAT3 2020 ·Circulation Research ·Shiju Ye, Wu Luo, Zia A. Khan, Gaojun Wu, Lina Xuan, Peiren Shan, Ke Lin, Taiwei Chen, Jingying Wang, Xiang Hu, Shengjie Wang, Weijian Huang, Guang Liang	194
20	Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury 2019 ·Journal of Medicinal Chemistry ·Zhiguo Liu, Lingfeng Chen, (unknown), Yali Zhang, (unknown), Chao‐Liang Wu, Wu Luo, (unknown), Chenglong Li, Guang Liang	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact